A “gold standard” for population health? Revisiting the FDA’s relationship with the Hippocratic Oath

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Gillian Woollett, Bruce S. Pyenson | 16 April 2018

Population health programs seek to improve the health outcomes broadly of populations as opposed to focusing on individuals. A population health paradigm can provide faster and better access to innovation- and better guidance for consumers. The Food and Drug Administration should use a population health context to meet 21st century expectations for pharmaceutical risk.

This article was published in Health Affairs.

Read or print the article